Navigation Links
New engineered drug may offer prolonged arthritis relief

Researchers at Duke University have devised a new way to significantly prolong the effects of an anti-inflammatory drug, potentially making it useful for providing longer-lasting treatment for osteoarthritis, the most common form of arthritis.

The modified drug, which would be injected directly into arthritic joints, could last for several weeks rather than just the few hours the unmodified drug would last, the researchers said.

In their study, the researchers modified a drug called interleukin-1 receptor antagonist (IL1RA). They found that the drug, which is a protein, could be improved by attaching a second protein that clumps together at normal body temperatures. The combined drug likewise would assemble into clumps in the body to serve as "drug depots" that gradually release active drug particles, the researchers said.

"Although the conventional drug is being used for autoimmune diseases, no one yet knows how much of it would be needed to achieve a therapeutic effect for osteoarthritis," said Lori Setton, associate professor of biomedical engineering and surgery. "Current estimates suggest it would require perhaps two injections per week of the unmodified drug.

"With this advance, we believe treatments could go from twice a week to perhaps twice a month, and that would be a huge clinical gain," she said.

By remaining at the site of disease, the drug also might cause fewer negative side effects than the unmodified drug, the researchers added.

The team reported an initial proof-of-concept study on Saturday, Oct. 14, at the Biomedical Engineering Society annual meeting, in Chicago. The team also has reported related findings online in the Journal of Controlled Release.

The work was supported by a Coulter Foundation Translational Research Partnership award to the biomedical engineering department at Duke's Pratt School of Engineering, and by the National Institutes of Health and a United Negro College Fund
'"/>

Source:Duke University


Page: 1 2 3 4

Related biology news :

1. Insects develop resistance to engineered crops
2. Genetically engineered animals help in scientific research that may benefit children
3. Genetically engineered mosquitoes show resistance to dengue fever virus
4. Bioengineered tissue implants regenerate damaged knee cartilage
5. Genetically engineered blood protein can be used to split water into oxygen and hydrogen
6. Can engineered immune cells stop AIDS?
7. Tissue engineered scaffolding allows reproduction of cartilage tissue
8. Ancient olfaction protein is shared by many bugs, offering new pest control target
9. Protein offers way to stop microscopic parasites in their tracks
10. Nanoparticles offer new hope for detection and treatment
11. Whats really making you sick? Plant pathologists offer the science behind Sick Building Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New engineered drug may offer prolonged arthritis relief

(Date:4/14/2015)... 14, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... 2015 New York Design Awards under the category  ,Product ... City Design Awards are part of a global multi-disciplinary ... ratings from the marketplace, industry and judging panel. Winners ...
(Date:4/10/2015)... 2015 Research and Markets ( ... "Security Competitive Profiles - NEC" report to their ... NEC will continue to supply a range of IT ... a company focus on the development of a Big ... opportunities in the Asia-Pacific region ...
(Date:4/6/2015)... Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/143028 for MINIATURE, MULTI-PURPOSE ANTENNA ... NXT-ID introduces a new revolutionary method ... surrounds the use of miniature antenna modules for ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... This release is also available in Spanish . ... Pediatrics of the University of Granada , ... 16 European countries, will study the effects of childrens ... allergies, weak bones, neuromotor functioning and childrens behavioural aspects. ...
... -- Proteins, the biological molecules involved in virtually every ... ways, according to a recent study from the U.S. ... new light on how proteins interact with drugs and ... to behave similarly in regions of high and low ...
... including biologists from NOAAs Fisheries Service, reported in the ... vaquita, a porpoise found in the Gulf of California, ... levels that their rate to extinction will increase and ... vaquita remain. The research team, led by Armando ...
Cached Biology News:Scientists study the link between children's nutrition and adult diseases 2New Argonne study may shed light on protein-drug interactions 2New Argonne study may shed light on protein-drug interactions 3
(Date:4/17/2015)... SYDNEY , April 17, 2015  US-Australian drug ... signed a Memorandum of Understanding with the Feinstein ... New York to collaborate with ... cancers. The collaboration brings together the ... and clinical expertise of the Feinstein Institute in ...
(Date:4/16/2015)... Bythewood, South Carolina (PRWEB) April 17, 2015 ... solutions and steam system services, released their newly ... 2015. The customer facing website effectively promotes ... proposition. , All the information that a ... training, steam system services, company capabilities, industries serviced, ...
(Date:4/16/2015)... Capillus, LLC announces plans to expand ... Europe and Asia. The Miami-based medical device manufacturer ... Business Development Director of Svenson Group Europe, as ... professional achievements include increasing the number of Svenson ... the Portuguese marketplace with centers in Lisbon and ...
(Date:4/16/2015)... 2015 According to the 2014 ... outside source was ranked first among the leading ... to lifting, pushing, pulling, holding, carrying, or throwing ... The David Round Company takes statistics like this ... hard to develop and design equipment that prevents ...
Breaking Biology Technology:Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6Spirax Sarco website has a new look 2Capillus, LLC Extends Laser Hair Therapy Products to Europe and Asia 2The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2
... Baxa Corporation announces its,2008 sponsorship for the Colorado ... of MicroPhage Inc.) recognized Baxa, along with,the other ... held April 29th at the University Club in ... CBSA since its inception. Company founder Brian,Baldwin was ...
... FRANKLIN LAKES, N.J., May 1 Brian T. Griffin,group ... MHS ),is scheduled to address the Deutsche Bank ... The company presentation at the Intercontinental Boston, will begin ... Robert S.,Epstein, MD, MS, will participate in a panel ...
... May 1 Osteotech, Inc.,(Nasdaq: OSTE ), a ... healing, announced today that revenue for the first quarter ... for the first,quarter of 2007. Revenue from the Company,s ... was $17.6 million for the three,months ended March 31, ...
Cached Biology Technology:Baxa Announces Colorado BioScience Association Sponsorship 2Baxa Announces Colorado BioScience Association Sponsorship 3Medco to Present at the Deutsche Bank 33rd Annual Health Care Conference 2Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10% 2Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10% 3Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10% 4Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10% 5
Shh Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Anti-human C5/C5b, Clone 568, Monoclonal Antibody...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
Biology Products: